Drug Shortage Report for TEVA-ATENOLOL/CHLORTHALIDONE
Report ID | 952 |
Drug Identification Number | 02302926 |
Brand name | TEVA-ATENOLOL/CHLORTHALIDONE |
Common or Proper name | Atenolol Chlorthalidone |
Company Name | TEVA CANADA LIMITED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | CHLORTHALIDONE ATENOLOL |
Strength(s) | 25MG 100MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C07CB |
ATC description | BETA BLOCKING AGENTS AND OTHER DIURETICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2016-11-01 |
Actual start date | 2016-10-17 |
Estimated end date | |
Actual end date | 2019-09-30 |
Shortage status | Resolved |
Updated date | 2020-01-21 |
Company comments | Item Discontinued |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2020-01-21 | French | Compare |
v5 | 2020-01-21 | English | Compare |
v4 | 2017-03-14 | French | Compare |
v3 | 2017-03-14 | English | Compare |
v2 | 2017-03-13 | French | Compare |
v1 | 2017-03-13 | English | Compare |
Showing 1 to 6 of 6